Transactions

Gyre Therapeutics, Inc.’s acquisition of Cullgen Inc

Date Announced:
03/02/2026

client:
The Special Committee of Gyre Therapeutics, Inc.’s Board of Directors

Status:
Pending

Value:
$300 million